Faecal Microbiota Transplantation
Faecal microbiota transplantation (FMT)—the transfer of gut microbiota from a healthy donor to a recipient—is now accepted as a treatment for recurrent Clostridium difficile infection. FMT is also considered promising as a treatment for other diseases, including IBD, metabolic disorders and IBS.
This online course is formed of two modules that address current indications, current evidence and future perspectives for FMT, the practical issues and technicalities of the procedure and the issues associated with developing an FMT centre. Live sessions are included for both the preparation and delivery of the faecal sample.
The combined video and audio footage has a total duration of approximately 100 minutes. The estimated time needed to complete the course, including the final assessment, is 2 hours.
This course was developed by: UEG.
- Acquire knowledge of the therapeutic avenues for the modulation of gut microbiota
- Be aware of the current evidence and future perspectives for FMT in the management of recurrent CDI, IBD, metabolic disorders and IBS in both children and adults
- Be aware of the current indications for FMT in clinical practice
- Be aware of the practical issues and technicalities of FMT (patient selection, donor screening, material preparation, routes of delivery, usefulness of deep microbiota sequencing)
- Acquire knowledge of the issues associated with the development of an FMT centre
C. Rune Stensvold, Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Giovanni Cammarota, MD, Associate Professor of Internal Medicine, Internal Medicine, Gastroenterology and Liver Unit, Agostino Gemelli University Hospital, Catholic University of Rome, Italy.
Antonio Gasbarrini, MD, Full Professor of Gastroenterology, Internal Medicine, Gastroenterology and Liver Unit, Agostino Gemelli University Hospital, Catholic University of Rome, Italy.
Gianluca Ianiro, MD, Internal Medicine, Gastroenterology and Liver Unit, Agostino Gemelli University Hospital, Catholic University of Rome, Italy.
Maurizio Sanguinetti, Luca Masucci, and Domenico Nagel
Targeted learners include gastroenterologists, endoscopists, internists, paediatricians, endocrinologists, surgeons, infectious disease specialists and clinical microbiologists who are interested in gut microbiota and who deal with diseases associated with gut microbiota perturbation (recurrent CDI, IBD, IBS, obesity, diabetes and other metabolic disorders).
- The course consists of two modules and lasts for approximately 2 hours in total and includes two live sessions (donor faecal sample preparation; FMT delivery)
- All authors and the course editor have declared that they have no conflicts of interest in relation to the material in this course
- The production of this course was funded entirely by UEG. No external sponsorship was received
- The material used in this course was prepared in 2016
- Learners are invited to test their knowledge at the beginning and the end of each module via a series of 2 x 10 MCQs for each module
- The modules in the course has a pass mark of 70%. Those scoring less than the required pass mark are encouraged to revisit the course and retake the assessment
Release Date: July 2016
This course, made available on www.ueg.eu and organised by United European Gastroenterology, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 2 European CME credits (ECMEC).
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.